| Pharmaceutical active ingredients: |
| Morphine Sulfate |
| Available forms, composition and doses of MS Contin: |
| Capsules; Oral; Morphine Sulfate 120 mgCapsules; Oral; Morphine Sulfate 30 mgCapsules; Oral; Morphine Sulfate 60 mgCapsules; Oral; Morphine Sulfate 90 mgSuppositories; Rectal; Morphine Sulfate 100 mgSuppositories; Rectal; Morphine Sulfate 200 mgSuppositories; Rectal; Morphine Sulfate 30 mgSuppositories; Rectal; Morphine Sulfate 60 mgTablets, Extended Release; Oral; Morphine Sulfate 10 mgTablets, Extended Release; Oral; Morphine Sulfate 100 mgTablets, Extended Release; Oral; Morphine Sulfate 15 mgTablets, Extended Release; Oral; Morphine Sulfate 200 mgTablets, Extended Release; Oral; Morphine Sulfate 30 mgTablets, Extended Release; Oral; Morphine Sulfate 5 mgTablets, Extended Release; Oral; Morphine Sulfate 60 mg |
| MS Contin medical category: |
| Human:Analgesics (opioid)Cough and cold preparationsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02AA01 - Morphine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Purdue PharmaMundipharmaViatris |
| Related documents and information about MS Contin: |
| MS Contin prescribing information (PDF) |